Miller Paul H, Rabu Gabrielle, MacAldaz Margarita, Knapp David J H F, Cheung Alice M S, Dhillon Kiran, Nakamichi Naoto, Beer Philip A, Shultz Leonard D, Humphries R Keith, Eaves Connie J
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Exp Hematol. 2017 Apr;48:41-49. doi: 10.1016/j.exphem.2016.12.012. Epub 2017 Jan 11.
Xenograft models are transforming our understanding of the output capabilities of primitive human hematopoietic cells in vivo. However, many variables that affect posttransplantation reconstitution dynamics remain poorly understood. Here, we show that an equivalent level of human chimerism can be regenerated from human CD34 cord blood cells transplanted intravenously either with or without additional radiation-inactivated cells into 2- to 6-month-old NOD-Rag1-IL2Rγc (NRG) mice given a more radioprotective conditioning regimen than is possible in conventionally used, repair-deficient NOD-Prkdc-IL2Rγc (NSG) hosts. Comparison of sublethally irradiated and non-irradiated NRG mice and W/W derivatives showed superior chimerism in the W-deficient recipients, with some differential effects on different lineage outputs. Consistently superior outputs were observed in female recipients regardless of their genotype, age, or pretransplantation conditioning, with greater differences apparent later after transplantation. These results define key parameters for optimizing the sensitivity and minimizing the intraexperimental variability of human hematopoietic xenografts generated in increasingly supportive immunodeficient host mice.
异种移植模型正在改变我们对原始人类造血细胞在体内输出能力的理解。然而,许多影响移植后重建动态的变量仍知之甚少。在这里,我们表明,在给予比传统使用的修复缺陷型NOD-Prkdc-IL2Rγc(NSG)宿主更具辐射防护性的预处理方案的2至6个月大的NOD-Rag1-IL2Rγc(NRG)小鼠中,无论是否添加经辐射灭活的细胞,静脉注射人CD34脐带血细胞都能再生出同等水平的人嵌合率。对亚致死剂量照射和未照射的NRG小鼠以及W/W衍生物的比较表明,W缺陷受体中的嵌合率更高,对不同谱系输出有一些差异影响。无论基因型、年龄或移植前预处理如何,在雌性受体中均观察到始终优越的输出,移植后后期差异更明显。这些结果定义了关键参数,以优化在越来越支持性的免疫缺陷宿主小鼠中产生的人类造血异种移植的敏感性并最小化实验内变异性。